These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9574635)

  • 1. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Hilton DA; Love S; Barber R; Ellison D; Sandeman DR
    Neurosurgery; 1998 Apr; 42(4):724-9. PubMed ID: 9574635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in p53, p21, and MIB-1 labeling index in primary human astrocytomas following radiation therapy.
    Henson JW; Hobbs W; Chakravarti A; Louis DN
    J Neurooncol; 2005 Sep; 74(2):151-4. PubMed ID: 16193385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.
    Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H
    J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Mastronardi L; Puzzilli F; Guiducci A
    Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870
    [No Abstract]   [Full Text] [Related]  

  • 6. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
    Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
    Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term molecular changes in WHO grade II astrocytomas following radiotherapy.
    Yue WY; Sai K; Wu QL; Xia YF; Yu SH; Chen ZP
    Chin J Cancer; 2012 Mar; 31(3):159-65. PubMed ID: 22313596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas.
    Tihan T; Davis R; Elowitz E; DiCostanzo D; Moll U
    Arch Pathol Lab Med; 2000 Jan; 124(1):108-13. PubMed ID: 10629140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in supratentorial WHO grade II astrocytoma in adults.
    Shinoda J; Sakai N; Nakatani K; Funakoshi T
    Br J Neurosurg; 1998 Aug; 12(4):318-24. PubMed ID: 10070423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for cerebellar astrocytomas in children: a study of 102 cases.
    Desai KI; Nadkarni TD; Muzumdar DP; Goel A
    Pediatr Neurosurg; 2001 Dec; 35(6):311-7. PubMed ID: 11786699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
    Jaros E; Perry RH; Adam L; Kelly PJ; Crawford PJ; Kalbag RM; Mendelow AD; Sengupta RP; Pearson AD
    Br J Cancer; 1992 Aug; 66(2):373-85. PubMed ID: 1503912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
    Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
    Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
    Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
    Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
    Bl├╝mcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
    Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.
    Lera J; Lara PC; Perez S; Cabrera JL; Santana C
    Cancer; 1998 Dec; 83(12):2493-501. PubMed ID: 9874454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.